| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 125.16B | 141.66B | 125.67B | 129.36B | 125.77B | 126.91B |
| Gross Profit | 22.50B | 25.57B | 23.34B | 19.84B | 24.48B | 19.23B |
| EBITDA | 13.61B | 16.27B | 14.52B | 11.61B | 16.06B | 12.16B |
| Net Income | 8.63B | 11.90B | 9.75B | 8.40B | 10.62B | 8.41B |
Balance Sheet | ||||||
| Total Assets | 152.05B | 175.37B | 155.08B | 153.02B | 147.04B | 131.74B |
| Cash, Cash Equivalents and Short-Term Investments | 43.74B | 35.42B | 42.61B | 42.17B | 48.94B | 19.65B |
| Total Debt | 14.19B | 15.24B | 14.11B | 14.99B | 15.59B | 15.04B |
| Total Liabilities | 37.73B | 47.42B | 40.01B | 52.43B | 57.50B | 51.31B |
| Stockholders Equity | 113.00B | 126.42B | 113.66B | 99.23B | 88.22B | 79.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -6.82B | -3.31B | -5.48B | 31.33B | -7.82B |
| Operating Cash Flow | 0.00 | -5.93B | -2.54B | -4.65B | 32.33B | 513.00M |
| Investing Cash Flow | 0.00 | 746.00M | 51.00M | -895.00M | -1.45B | -8.68B |
| Financing Cash Flow | 0.00 | -1.87B | 2.63B | -1.67B | -1.60B | -3.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥111.02B | 9.62 | ― | 1.55% | 17.21% | 65.71% | |
79 Outperform | ¥123.54B | 14.37 | ― | 2.14% | 4.78% | 50.65% | |
75 Outperform | ¥153.51B | 12.05 | ― | 2.81% | 12.49% | 26.21% | |
72 Outperform | ¥275.79B | 17.88 | 8.53% | 2.45% | 3.59% | 44.73% | |
70 Outperform | ¥264.94B | 13.93 | ― | 2.79% | 5.66% | 38.20% | |
66 Neutral | ¥163.53B | 13.58 | ― | 2.72% | 12.72% | 17.23% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |